Objectives: To investigate the impact of postoperative time to nadir of estimated glomerular filtration rate on renal functional changes after robot-assisted partial nephrectomy. Methods: From 2006 to 2015, 287 patients with renal mass who underwent robotassisted partial nephrectomy in a referral center were analyzed. The cohort was evaluated based on their time to develop nadir: group 1 (no nadir), group 2 (<48 h) and group 3 (≥48 h). The outcome measures were to evaluate the renal function recovery between groups, risk factors for development of nadir ≥48 h, as well as predictors of chronic kidney disease upstaging. Results: The mean estimated glomerular filtration rate percentage change was the worst in group 3 compared with groups 1 and 2, with 13.8%, À0.67% and 8%, respectively (P < 0.001). Chronic kidney disease upstaging was more common in group 3 compared with the other groups (P < 0.001). Age, tumor size, PADUA score and warm ischemia time were predictors of developing ≥48 h estimated glomerular filtration rate nadir (odds ratio 1.04, P = 0.002; odds ratio 1.43, P < 0.001; odds ratio 1.24, P = 0.018; odds ratio 1.05, P < 0.001), respectively. The 5-year probability of freedom from chronic kidney disease upstaging was lower in group 3 (75.6%) compared with the other groups -88.1% and 100% (P = 0.003). Time to nadir ≥48 h was a predictor of chronic kidney disease upstaging (odds ratio 3.02, P = 0.022). Conclusions: A continuous decline in estimated glomerular filtration rate (≥48 h) after partial nephrectomy is associated with increased risk of poor functional recovery overtime. Age, tumor size, PADUA score and warm ischemia time are independent predictors of developing ≥48 h time to nadir of estimated glomerular filtration rate. This higher risk subgroup should be targeted for stricter follow up to allow early detection of future risk of renal functional decline.
Introduction
Whenever technically feasible, PN is recommended for the treatment of T1 renal tumors. 1 Several studies have proved that PN is associated with a lower risk of postoperative newonset CKD), 2 as well as protecting against end-stage renal disease and the need for dialysis relative to radical nephrectomy. 3 Despite the protective effect of PN on renal function, renal functional decline is nevertheless present. Resections of normal parenchyma and ischemic insult to remnant nephrons have been established as risks of PN. Clark et al. reported that one-third of patients with preoperative CKD I or II will progress to CKD stage III after PN. 4 In light of this, many studies have focused on differences in preoperative eGFR and their subsequent risk for the development of new-onset CKD after PN. 5, 6 These cumulative efforts put the value of weighing the risks of PN and adverse sequela related to renal insufficiency with risk of cancer progression.
Although preoperative details might help to predict postoperative renal function recovery, continuously searching for postoperative factors predictive of renal function trends might provide new insights for prognostication. Indeed, a study has reported that aside from current eGFR, relative previous changes in renal function have also been shown to have an impact on future renal disease progression. 7 Lane et al. also reported that a longer time to develop nadir eGFR after PN predicted worse postoperative renal function. 8 However, no one has investigated the effect of actual chronological time to nadir on postoperative renal function changes. Theoretically, within an acceptable ischemia time, arbitrary changes in postoperative renal function are usually masked by functional compensation of the contralateral kidney. 9 Thus, we hypothesize that with a normal-functioning contralateral kidney, longer postoperative eGFR time to nadir should not be observed.
In the present study, we aimed to investigate the impact of eGFR's time to nadir on renal functional recovery and to identify the factors associated with a longer time to nadir.
Methods
We retrospectively reviewed the records of 310 consecutive patients who underwent PN by a single surgeon (KHR) in our institutional review board-approved database (2014-0091-001) between September 2006 and December 2015. Patients with preoperative CKD stage ≥3, incomplete data, <12 month follow up, and multiple and synchronous tumors were excluded. A total of 287 patients met our criteria and were included in the study. Nadir eGFR was defined as the lowest eGFR measured within 1 week after surgery. Postoperative eGFR nadir was reported to occur at a median of 2 days. 8 Hence, to identify the impact of postoperative time to nadir of eGFR, we divided the patients into three groups based on their time to reach eGFR nadir: group 1 (n = 81, no nadir), group 2 (n = 112, <48 h) and group 3 (n = 94, ≥48 h).
The eGFR was calculated using the MDRD formula. 10 All eGFR measurements were carried out in the same laboratory after surgery and during follow up. Patients demographic characteristics and perioperative data were analyzed, including age, BMI, ASA score, preoperative eGFR, preoperative CKD stage, PADUA score, tumor size, OT, WIT, clamp type and EBL. Postoperative outcomes included complications based on the Clavien Classification, CKD stage and CKD upstaging.
CKD stage was classified using National Kidney Foundation definition. The main outcome measure was to evaluate renal functional recovery between groups. The secondary outcome measures were to investigate the factors predicting eGFR's ≥48 h time to nadir, as well as predictors of CKD upstaging. CKD upstaging was defined as new-onset CKD ≥III at longest follow up. Percentage change in eGFR was calculated using the following formula: 100 9 (preoperative eGFR-postoperative eGFR / preoperative eGFR), and was compared between groups.
All RAPN procedures were carried out using the da Vinci Surgical system (Intuitive Surgical, Sunnyvale, CA, USA) using a technique that was previously described. Specimens were analyzed by a dedicated pathologist, and tumor extent was classified based on American Joint Committee on Cancer TNM classification. A positive surgical margin was defined as cancer cells at the inked surface of parenchymal excision.
Postoperative follow up included medical history, physical examination, eGFR measurements, and other tests as indicated at 1, 3, 6, 12 months and yearly thereafter. Likewise, abdominal computed tomography or magnetic resonance imaging was carried out within 3-12 months after surgery, and annually up to 3 years based on patients' risk.
The present study was approved by the ethical committee review board of Yonsei Medical School of Medicine. The ethical approval number is 2014-0091-001.
Statistical analysis
Demographic and perioperative data were analyzed using descriptive statistics. Proportions were used for categorical variables, and mean (standard deviation) or median (interquartile range) for continuous variables. ANOVA and the Kruskal-Wallis H-test were used to compare differences between the three groups for continuous variables, whereas the v 2 -test and Fisher's exact test were used for categorical variables.
A univariable and multivariable regression analysis was carried out to identify the association with development of nadir at ≥48 h and the related factors. We included in our model the statistically significant (P < 0.05) clinical and operative variables between the three nadir groups, which are age, preoperative eGFR, WIT, EBL, PADUA score and hilar clamp type (Tables 1,2 ). Because tumor size is an important component of the PADUA score and both are covariates, we used two multivariable analysis models where tumor size supplanted the PADUA score in model 2. Similarly, a multivariable regression analysis was used to test the risk factors of CKD upstaging with two models (PADUA score supplanted tumor size in model 2).
The Kaplan-Meier curve was used to analyze CKD upstaging-free progression between groups. All tests were two-sided and statistical significance was set at P < 0.05. All statistical analyses were carried out using Statistical Package for Social Science (SPSS) for Windows version 22.0 (SPSS, Chicago, IL, USA).
Results
The study included 287 patients, with their demographic characteristics summarized in Table 1 . Among them, 28.2% had no nadir (81/287), 39% had eGFR nadir at <48 h (112/ 287) and 32.8% had eGFR nadir at ≥48 h (94/287). eGFR was measured for all patients (n = 287) in the first day after surgery, for day 2 (n = 240), day 3 (n = 260), day 4 (n = 119), day 5 (n = 98), day 6 (n = 114) and day 7 (n = 54). There was no significant difference in BMI, preoperative eGFR and ASA score (P = 0.150, P = 0.938 and P = 0.873, respectively). The overall preoperative eGFR was 88.5 AE 15.1 mL/min per 1.73 m 2 . The median patient age of the cohort was 51 (interquartile range 44-60), and group 3 patients tended to be older, with a mean age of 54 AE 12 years compared with the other groups (P = 0.016).
In contrast, tumor size and PADUA score significantly differed across the groups, such that patients in group 1 had smaller tumors and lower PADUA scores than those in group 3 (P = 0.000 and P = 0.000). The median follow-up period was 36.5 months, and the median length of hospital stay was 4 days.
Perioperative and postoperative outcomes are presented in Table 2 . Group 3 patients had longer OT, WIT and EBL; 182.5 AE 85, 26.2 + 11.7 and 400 (150-700), respectively (P = 0.001, P = 0.000 and P = 0.000, respectively). Off-clamping RAPN was carried out mostly in group 1 compared with groups 2 and 3; 46.9%, 13.4% and 6.4%, respectively (P = 0.000). Overall, 82.9% experienced no complications, and the complication rate did not significantly differ between groups (P = 0.074). Grade 3 complications occurred in 0.7% (n = 2), one patient in group 2 experienced rebleeding from the operative site requiring segmental angioembolization and one patient from group 3 had urinoma requiring stent insertion. Grade 2 and grade 1 complications were seen in 3.5% and 12.9% of patients, and mostly as blood transfusion and fever. Clear cell renal cell carcinoma was the predominant histological type seen among the groups, with 70.4% incidence overall (202/287).
The mean postoperative eGFR trend for each group is plotted in Figure 1a . During the first postoperative week, renal function was observed to stabilize soon after nadir eGFR was reached. On average, group 3 patients experienced slower renal function recovery, with a mean eGFR of 73.2 AE 16.8, 74.9 AE 15.3, 74.3 AE 18.3 and 76.2 AE 18.4 at 1, 3, 6 and 12 months, respectively. The cumulative eGFR percentage change for each group showed that group 3 had the worst changes in eGFR during follow up (P = 0.000; Fig. 1b) .
Furthermore, changes in renal function were observed to stabilize from the 6th postoperative month onwards.
During follow up, 9.1% of the cohort experienced CKD upstaging. Group 3 had the most numbers of upstaged patients compared with groups 2 and 1, with 18.1%, 8% and 0%, respectively (P = 0.000). At longest follow up, the incidence of CKD stage 3 patients was higher in group 3 compared with the other groups, with 18.1%, 8.9% and 0%, respectively (P = 0.004). Figure 2 shows that the 5-year probability of freedom from CKD upstaging was lower in group 3 (75.6%) compared with other groups -88.1% and 100% (P = 0.003). Table 3 presents the univariable and multivariable regression analysis of the predictors of eGFR nadir ≥48 h using preoperative and perioperative variables. In model 1, we noted that age, WIT and PADUA score were predictors of developing ≥48 h eGFR nadir (OR 1.04, P = 0.002; OR 1.05, P < 0.001; OR 1.24, P = 0.018), respectively. Whereas in model 2, age, tumor size and WIT were predictors of developing ≥48 h eGFR nadir (OR 1.05, P < 0.001; OR 1.43, P < 0.001; OR 1.05, P = 0.001), respectively. Table 4 presents the univariable and multivariable regression analysis of the predictors of CKD upstaging using preoperative and perioperative variables. In model 1, we noted that age, preoperative eGFR, tumor size and time to nadir ≥48 h were predictors for developing CKD stage ≥III (OR 1.08, P = 0.001; OR 0.94, P = 0.003; OR 1.39, P = 0.003; OR 3.08, P = 0.020), respectively. Whereas in model 2, age, preoperative eGFR, PADUA score and time to nadir ≥48 h were predictors of developing CKD stage ≥III (OR 1.08, P = 0.001; OR 0.94, P = 0.007; OR 1.37, P = 0.032; OR 3.02, P = 0.022), respectively.
Discussion
In the present study, we found that patients who develop nadir ≥48 h have an increased likelihood of poor functional recovery at long-term follow up. Surmountable time to nadir should not be apparent in the presence of perfectly working kidneys. Mir et al. reported that the operated kidney should be able to recover within 2 days along with a median 6% increase in function of the contralateral kidney during the first week. 11, 12 Likewise, Lane et al. reported that generally soon after the nadir is reached the renal function started to stabilize. 8 Hence, a continuous decline in eGFR after 48 h might forewarn a delayed or even poor compensatory function of the contralateral kidney. We hypothesize that a longer time to nadir might be due to an increased lag in compensatory mechanism, which is shown by various ranges of contralateral compensation. 11 In contrast, those patients who did not develop nadir postoperatively experienced better functional recovery and no CKD upstaging. According to Choi et al., functional compensation occurs first before an actual hypertrophy, regardless of CKD stage. 13 Their finding further supports our theory that those who do not develop nadir show excellent functional compensation of the contralateral kidney.
Kidneys are end organs highly sensitive to hypoperfusion and anoxia. Changes in oxygen availability and perfusion are highly regulated by mechanisms in the medullary region and tubuloglomerular feedback. Thus, any sensible decline in blood flow and oxygen triggers the tubuloglomerular feedback to redistribute the corticomedullary circulation.
14 Failure of this mechanism due to hypoxic episodes might lead to acute tubular damage and later tubulointerstitial changes reflected in glomerular filtration. 15 We speculate that these subclinical impairments might have occurred among the patients who developed prolonged time to nadir. Following this thought, on univariable analysis, long WIT and hilar clamping were associated with development of ≥48 h time to nadir. However, clamp type was no longer significant in the multivariable model. This could be due the wide range of ischemia time, and the protective effect of non-clamp cases on preventing nadir development, which were not included in the WIT estimation. Likewise, a comparable number of patients who underwent clamping (total-/ selective-clamp) might have brought about this effect in our cohort.
In the midst of association of time to nadir and renal function recovery, we sought to identify relevant factors associated with the development of prolonged time to nadir. A significant association between patient age and having ≥48 h time to nadir was observed in our cohort. We note that younger patients tend to have a relatively greater number of healthy and functioning nephrons compared with elderly patients who are more vulnerable to postoperative decline in renal function after surgery. 16 Increasing tumor size and tumor complexity were also found to be associated with the development of ≥48 h time to nadir. It is possible and perhaps likely that larger tumors result in the excision of greater parenchyma with a resultant decrease in renal function. 8 Additionally, a larger defect brought about by a large tumor might have resulted in greater ischemized nephrons during renorrhaphy leading to a decline in eGFR postoperatively. Similarly, highly complex tumors are usually large, endophytic and/or hilar, and require long ischemia time for repair and to control bleeding, as well as usually being associated with resection of a wider healthy parenchymal safety margin. Recently, Lee et al. found that the PADUA score was significantly correlated with the percentage change in eGFR at 6 months postoperatively (P = 0.005). A 1-point increase in the PADUA score was associated with an eGFR decrease of >20% at 6 months after RAPN (P = 0.076). 17 Similarly, Mehrazin et al. found that for each 1-point increase in RENAL score, there was a 2.5% decrease in eGFR (P = 0.002), and for each 1-cm increase in tumor size, there was a 1.8% decrease in eGFR (P = 0.013).
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Of note, the mean EBL was significantly higher in patients with time to nadir ≥48 h. On univariable analysis, EBL was a potential risk factor for prolonged nadir time ≥48 h. However, it is no longer a significant factor in multivariable models; it is worth discussing the possible mechanisms that might explain the effect of blood loss on time to nadir. When there is a decrease in circulating blood, it triggers vasoconstriction and activation of the rennin-angiotensin aldosterone system. This leads to a decrease in GFR and filtered solute load in the kidneys. 19 Interestingly, a significantly higher blood loss was observed in group 3 patients, with a median of 400 cc. In a study of postoperative renal function after RAPN, it was reported that a blood loss of >200 cc is associated with greater postoperative decline in eGFR. 16 In addition, Colli et al. reported that intraoperative blood loss adversely affects the early and late postoperative renal function. 20 Therefore, this could partly explain why the patients with higher blood loss showed longer time to nadir.
The present results showed that prolonged time to nadir was associated with the development of CKD upstaging. Time to nadir ≥48 h was a predictor of CKD upstaging, together with increased age, lower preoperative eGFR, large tumor size and high tumor complexity. We suggest that time to nadir as a novel predictor to postoperative renal function might have an important role in follow up and monitoring of patients at risk after surgery. Our time to nadir hypothesis supports the results of Lane et al., which show that a longer period of decline in renal function would result in a lower ultimate GFR. 5 However, the present results showed that at ≥48 h time to nadir of eGFR, poorer functional recovery might be observed. Furthermore, Kovesdy et al. reported that aside from current eGFR, past decline in eGFR has a hazard ratio of 2.28 (95% CI 1.88-2.76) in developing end-stage renal disease. 7 Although patients who receive PN might gain survival benefits, it is imperative to monitor for CKD progression postoperatively. 4, 5 In the present cohort, we found 93% freedom from new-onset CKD stage 3, which is also comparable with the 60-month rate reported in a multi-institutional cohort by Kim et al. 21 This suggests that this early postoperative eGFR trend can be used as a guide on how postoperative renal functional recovery would surmise. Among patients who underwent RAPN, time to nadir can be used as an inkling sign to future renal function outcomes. In the first week after surgery, we suggest to have at least two eGFR measurements, one within the first 2 days, and the second after and before patient discharge. These measurements should account for patients who had continuous eGFR decline after 2 days. Hence, those patients should be advised closer follow up in the future due to increased tendency to have poorer functional recovery.
Interestingly, WIT and hilar clamp type were not among the risk factors of developing long-term CKD upstaging. Indeed, the impact of long WIT on postoperative renal function is maximized in the setting of a single renal unit. 22 In the presence of two renal functioning units, its impact is present on the short term. 23 Recovery of renal function after PN takes up to 1 year to stabilize, thus evaluating the risk factors affecting early postoperative renal function might be changed on the long-term. 24 Kallingal et al. found that the kidney ischemic changes at the cellular level recovered after reperfusion with no correlation between renal functional at 1 year and WIT. 23 Previously, we analyzed the impact of different clamp type on renal function outcomes. Off-clamp and selective-clamp had significantly less deterioration of postoperative renal function compared with total-clamp only in the first 3 months after surgery. 25 Some readers might think that there is some discrepancy between our previous results and the time to nadir hypothesis. 25 On examining the present study, although hilar clamp type significantly differed between the nadir groups, on the multivariable analysis it was no longer a significant factor in predicting nadir ≥48 h. Furthermore, time to nadir ≥48 h is not affected by clamp type only, but several predictors are included, such as age, tumor size, tumor complexity and length of ischemia time. Of note, age in our previous study outweighed the hilar clamp type as a predictor of renal function at 1 year. 25 Furthermore, the sample size and number of clamp types were different in both studies.
Interestingly, Lane et al. evaluated factors affecting the postoperative renal function in 660 patients with solitary kidney undergoing PN. 26 They found that increasing age, larger tumor size, lower preoperative eGFR and longer ischemia time are associated with decreased postoperative eGFR (P < 0.05). However, the percentage of parenchyma volume remained, and the preoperative eGFR (non-modifiable factors) predominated over ischemia time (modifiable) when included in the analysis.
Of note, there are two equations for eGFR estimation, the MDRD and the CKD-EPI. The CKD-EPI has been introduced as an alternative equation, which uses the same four variables used in the MDRD equation (age, sex, race and serum creatinine), but applies different coefficients. 27 Different studies reported that the CKD-EPI equation estimates eGFR more accurately than the MDRD equation, 27, 28 however, other did not find a difference; 29 in addition, the application of CKD-EPI equation in the elderly has yet to be elucidated. 30 Superiority of the CKD-EPI equation over the MDRD equation is predominant in people with higher levels of kidney function. 31 In the current research, we used the MDRD equation for eGFR estimation, as most of our laboratories used the MDRD equation in reporting eGFR. 10 Similarly, 92% of laboratories in the USA still used the MDRD equation in reporting eGFR, with just 4% using the CKD-EPI equation. 32 In addition, we preferred to be adherent to most of the previous urology PN research, which used the MDRD equation. 4, [16] [17] [18] [19] [21] [22] [23] [24] [25] The present study had a number of limitations, such as a retrospective design and a single expert surgeon. The MDRD formula is an estimate of GFR, and might not consistently represent the actual renal function of patients. Furthermore, measurement of the functional status of each kidney unit was not available due to a lack of renal scans that could better show adaptations of both the operated and contralateral kidney. However, repeated renal scans after RAPN might not sound plausible. The generalizability of the present results will require further prospective studies in larger cohorts with split functional study. Another limitation was that we could not assess the impact of cold ischemia on postoperative time to nadir eGFR. This shortening is owed to our RAPN technique, as we did not apply the cold ischemia during surgery. Future assessment and comparison between warm and cold ischemia on postoperative nadir and its consequences should be carried out. Another point we should refer to is the relatively small number of CKD upstaging events included in the multivariable logistic model might weaken the analysis. However, both models confirm its impact on the CKD upstaging occurrence; furthermore, the Kaplan-Meyer survival analysis supports the significant impact of nadir ≥48 h of CKD upstaging.
Despite these limitations, the results of the present study might suggest that urologists should counsel patients about the likely impact their postoperative time to nadir may have on their renal functional recovery. Likewise, this is the first study to convey that postoperative time to nadir can be used as a surrogate of future renal function outcome.
In summary, patients who develop eGFR time to nadir (≥48 h) are associated with poor functional recovery and the risk of renal function deterioration on long-term follow up. Elderly patients with larger tumors and high PADUA scores should be monitored closely after PN due to increased risk of longer time to nadir. Modifiable factors, such as increased blood loss and prolonged WIT, should also be avoided. Using the length of time to nadir (≥48 h), we can integrate a strict follow up to allow early detection of future risk of renal functional decline among patients who undergo PN.
